Operating
D&A
Guardant Health D&A decreased by 6.0% to $9.44M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.8%, from $10.24M to $9.44M. Over 4 years (FY 2021 to FY 2025), D&A shows an upward trend with a 15.6% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher values indicate significant capital investment in long-term assets.
Detailed definition
This represents the non-cash allocation of the cost of tangible and intangible assets over their useful lives. Because t...
Peer comparison
Common in capital-intensive industries; varies based on asset base size.
Metric ID:
depreciation_and_amortization_cfHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.63M | $5.54M | $6.09M | $7.2M | $8.79M | $9.81M | $10.17M | $10.35M | $10.63M | $11.04M | $10.87M | $10.71M | $10.62M | $10.6M | $10.45M | $10.24M | $10.04M | $9.41M | $10.05M | $9.44M |
| QoQ Change | — | -1.5% | +9.8% | +18.2% | +22.0% | +11.6% | +3.7% | +1.7% | +2.8% | +3.8% | -1.5% | -1.4% | -0.8% | -0.2% | -1.4% | -2.1% | -1.9% | -6.3% | +6.8% | -6.0% |
| YoY Change | — | — | — | — | +56.1% | +76.9% | +67.0% | +43.7% | +21.0% | +12.5% | +6.9% | +3.5% | -0.1% | -4.0% | -3.8% | -4.4% | -5.5% | -11.2% | -3.9% | -7.8% |
Range$5.54M – $11.04M
CAGR+11.5%
Avg YoY Growth+15.4%
Median YoY Growth+1.7%
D&A at Other Companies
Frequently Asked Questions
- What is Guardant Health's d&a?
- Guardant Health (GH) reported d&a of $9.44M in Q1 2026.
- How has Guardant Health's d&a changed year-over-year?
- Guardant Health's d&a decreased by 7.8% year-over-year, from $10.24M to $9.44M.
- What is the long-term trend for Guardant Health's d&a?
- Over 4 years (2021 to 2025), Guardant Health's d&a has grown at a 15.6% compound annual growth rate (CAGR), from $22.27M to $39.74M.
- What does d&a mean?
- Non-cash expenses related to the wear and tear or expiration of assets.